$3.4 Billion is the total value of PFM Health Sciences, LP's 85 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 51.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $171,024,000 | +15.1% | 1,561,290 | -1.6% | 5.03% | +7.9% |
| OM | OUTSET MED INC | $146,674,000 | -1.1% | 2,966,712 | 0.0% | 4.31% | -7.2% | |
| LLY | LILLY ELI & CO | $121,406,000 | +0.7% | 525,455 | 0.0% | 3.57% | -5.6% | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $119,639,000 | +24.5% | 3,431,010 | -1.9% | 3.52% | +16.8% |
| CYTK | Buy | CYTOKINETICS INC | $112,928,000 | +238.2% | 3,159,701 | +87.3% | 3.32% | +217.5% |
| ABBV | Sell | ABBVIE INC | $98,862,000 | -5.3% | 916,496 | -1.1% | 2.91% | -11.2% |
| New | ERASCA INC | $98,172,000 | – | 5,191,405 | +100.0% | 2.89% | – | |
| HCA | HCA HEALTHCARE INC | $94,784,000 | +17.4% | 390,507 | 0.0% | 2.79% | +10.2% | |
| MYGN | Sell | MYRIAD GENETICS INC | $92,767,000 | -1.8% | 2,872,918 | -7.0% | 2.73% | -7.9% |
| New | CARIBOU BIOSCIENCES INC | $88,176,000 | – | 4,092,309 | +100.0% | 2.59% | – | |
| IQV | IQVIA HLDGS INC | $85,735,000 | -1.1% | 357,916 | 0.0% | 2.52% | -7.2% | |
| AVTR | AVANTOR INC | $85,058,000 | +15.2% | 2,079,657 | 0.0% | 2.50% | +8.0% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $82,874,000 | -23.7% | 864,079 | -22.6% | 2.44% | -28.4% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $72,061,000 | +1.1% | 520,786 | +6.9% | 2.12% | -5.2% |
| MCK | Sell | MCKESSON CORP | $69,620,000 | +2.2% | 349,181 | -2.0% | 2.05% | -4.1% |
| New | GILEAD SCIENCES INCcall | $67,314,000 | – | 963,700 | +100.0% | 1.98% | – | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $63,077,000 | +114.1% | 3,283,570 | +9.8% | 1.86% | +101.0% |
| SGEN | Sell | SEAGEN INC | $61,914,000 | -18.8% | 364,630 | -24.5% | 1.82% | -23.8% |
| New | UNITEDHEALTH GROUP INCcall | $61,424,000 | – | 157,200 | +100.0% | 1.81% | – | |
| CNC | Sell | CENTENE CORP DEL | $61,367,000 | -19.5% | 984,871 | -5.8% | 1.80% | -24.5% |
| New | SELECT SECTOR SPDR TRcall | $60,131,000 | – | 1,602,200 | +100.0% | 1.77% | – | |
| EW | EDWARDS LIFESCIENCES CORP | $58,077,000 | +9.3% | 513,005 | 0.0% | 1.71% | +2.6% | |
| UNH | UNITEDHEALTH GROUP INC | $56,773,000 | -2.4% | 145,295 | 0.0% | 1.67% | -8.5% | |
| HUM | Sell | HUMANA INC | $54,255,000 | -13.9% | 139,420 | -2.1% | 1.60% | -19.3% |
| DHR | DANAHER CORPORATION | $53,487,000 | +13.4% | 175,690 | 0.0% | 1.57% | +6.4% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $53,169,000 | +14.7% | 300,545 | +4.7% | 1.56% | +7.6% |
| ICUI | Sell | ICU MED INC | $51,481,000 | -2.2% | 220,587 | -13.7% | 1.51% | -8.2% |
| New | HORIZON THERAPEUTICS PUB Lcall | $48,132,000 | – | 439,400 | +100.0% | 1.42% | – | |
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $47,675,000 | -0.3% | 45,910,000 | 0.0% | 1.40% | -6.5% | ||
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $47,192,000 | +277.7% | 785,748 | +276.7% | 1.39% | +254.1% |
| PEN | Buy | PENUMBRA INC | $47,194,000 | +28.7% | 177,088 | +32.4% | 1.39% | +20.8% |
| GILD | GILEAD SCIENCES INC | $46,562,000 | +1.4% | 666,601 | 0.0% | 1.37% | -4.9% | |
| NVRO | Sell | NEVRO CORP | $45,712,000 | -34.1% | 392,786 | -6.2% | 1.34% | -38.2% |
| THC | TENET HEALTHCARE CORP | $44,320,000 | -0.8% | 667,073 | 0.0% | 1.30% | -7.0% | |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $44,256,000 | -8.1% | 48,150,000 | 0.0% | 1.30% | -13.8% | ||
| WAT | WATERS CORP | $42,031,000 | +3.4% | 117,634 | 0.0% | 1.24% | -3.0% | |
| ICLR | Buy | ICON PLC | $41,447,000 | +39.0% | 158,183 | +9.7% | 1.22% | +30.5% |
| NVAX | Buy | NOVAVAX INC | $40,883,000 | +29.1% | 197,208 | +32.3% | 1.20% | +21.2% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $40,817,000 | +132.3% | 71,442 | +105.1% | 1.20% | +117.8% |
| New | BRISTOL-MYERS SQUIBB COcall | $36,212,000 | – | 612,000 | +100.0% | 1.06% | – | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $35,482,000 | -3.7% | 1,856,738 | -13.4% | 1.04% | -9.6% |
| New | SOPHIA GENETICS SAordinary shares | $35,455,000 | – | 2,022,552 | +100.0% | 1.04% | – | |
| HRTX | Buy | HERON THERAPEUTICS INC | $32,001,000 | -6.2% | 2,993,546 | +36.1% | 0.94% | -12.1% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $28,597,000 | +28.9% | 3,848,822 | +18.0% | 0.84% | +21.0% |
| CANO | CANO HEALTH INC | $26,555,000 | +4.8% | 2,094,279 | 0.0% | 0.78% | -1.6% | |
| New | NEUROCRINE BIOSCIENCES INCcall | $25,080,000 | – | 261,500 | +100.0% | 0.74% | – | |
| AERI | AERIE PHARMACEUTICALS INC | $24,883,000 | -28.8% | 2,182,684 | 0.0% | 0.73% | -33.2% | |
| NTLA | INTELLIA THERAPEUTICS INC | $23,908,000 | -17.1% | 178,222 | 0.0% | 0.70% | -22.2% | |
| CTLT | New | CATALENT INC | $23,660,000 | – | 177,800 | +100.0% | 0.70% | – |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $22,766,000 | +47.3% | 4,403,574 | +21.4% | 0.67% | +38.2% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $21,664,000 | -1.7% | 177,091 | -8.4% | 0.64% | -7.8% |
| IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $21,133,000 | -1.1% | 23,000,000 | 0.0% | 0.62% | -7.3% | ||
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $19,939,000 | +26.0% | 775,819 | +27.9% | 0.59% | +18.1% |
| BFLY | BUTTERFLY NETWORK INC | $19,088,000 | -27.9% | 1,828,311 | 0.0% | 0.56% | -32.4% | |
| MOH | MOLINA HEALTHCARE INC | $19,016,000 | +7.2% | 70,088 | 0.0% | 0.56% | +0.5% | |
| ISEE | New | IVERIC BIO INC | $18,483,000 | – | 1,138,112 | +100.0% | 0.54% | – |
| New | STEVANATO GROUP S P A | $13,895,000 | – | 549,002 | +100.0% | 0.41% | – | |
| New | SIGHT SCIENCES INC | $10,976,000 | – | 483,538 | +100.0% | 0.32% | – | |
| AVIR | New | ATEA PHARMACEUTICALS INC | $10,607,000 | – | 302,532 | +100.0% | 0.31% | – |
| GH | Sell | GUARDANT HEALTH INC | $10,558,000 | -77.3% | 84,455 | -77.4% | 0.31% | -78.7% |
| ZLAB | ZAI LAB LTDadr | $10,473,000 | -40.5% | 99,375 | 0.0% | 0.31% | -44.1% | |
| New | DYNAVAX TECHNOLOGIES CORPcall | $10,024,000 | – | 521,800 | +100.0% | 0.30% | – | |
| FSII | FS DEVELOPMENT CORP II | $9,950,000 | -0.5% | 1,000,000 | 0.0% | 0.29% | -6.4% | |
| DXCM | New | DEXCOM INC | $9,576,000 | – | 17,510 | +100.0% | 0.28% | – |
| PMVP | PMV PHARMACEUTICALS INC | $8,592,000 | -12.8% | 288,334 | 0.0% | 0.25% | -18.1% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $8,420,000 | +1.2% | 455,374 | 0.0% | 0.25% | -5.0% | |
| New | HUMANA INCcall | $8,172,000 | – | 21,000 | +100.0% | 0.24% | – | |
| NOVAVAX INCnote 3.750% 2/0 | $7,354,000 | -3.4% | 4,250,000 | 0.0% | 0.22% | -9.6% | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $6,864,000 | -1.6% | 400,000 | 0.0% | 0.20% | -7.8% | |
| FLDM | FLUIDIGM CORP DEL | $6,462,000 | +7.0% | 980,505 | 0.0% | 0.19% | +0.5% | |
| LFST | LIFESTANCE HEALTH GROUP INC | $6,432,000 | -48.0% | 443,595 | 0.0% | 0.19% | -51.2% | |
| KNTE | KINNATE BIOPHARMA INC | $6,084,000 | -1.1% | 264,293 | 0.0% | 0.18% | -7.3% | |
| LUNG | PULMONX CORP | $4,914,000 | -18.5% | 136,576 | 0.0% | 0.14% | -23.8% | |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $4,869,000 | – | 143,297 | +100.0% | 0.14% | – |
| BIIB | Sell | BIOGEN INC | $4,783,000 | -89.6% | 16,900 | -87.2% | 0.14% | -90.2% |
| CERT | CERTARA INC | $4,734,000 | +16.8% | 143,028 | 0.0% | 0.14% | +9.4% | |
| BLSA | BCLS ACQUISITION CORP | $4,641,000 | -5.0% | 464,103 | 0.0% | 0.14% | -11.1% | |
| JYAC | JIYA ACQUISITION CORP | $4,539,000 | -1.6% | 464,103 | 0.0% | 0.13% | -8.3% | |
| VECT | Sell | VECTIVBIO HLDG AG | $4,208,000 | -40.9% | 544,706 | -10.9% | 0.12% | -44.4% |
| New | MIRATI THERAPEUTICS INCcall | $2,654,000 | – | 15,000 | +100.0% | 0.08% | – | |
| BYSI | New | BEYONDSPRING INC | $2,548,000 | – | 161,697 | +100.0% | 0.08% | – |
| New | PROCEPT BIOROBOTICS CORP | $2,480,000 | – | 65,000 | +100.0% | 0.07% | – | |
| SBTX | SILVERBACK THERAPEUTICS INC | $1,879,000 | -67.7% | 188,243 | 0.0% | 0.06% | -69.8% | |
| New | ADAPTIMMUNE THERAPEUTICS PLCcall | $1,509,000 | – | 291,800 | +100.0% | 0.04% | – | |
| ALNA | ALLENA PHARMACEUTICALS | $256,000 | -30.8% | 284,285 | 0.0% | 0.01% | -33.3% | |
| DOCS | Exit | DOXIMITY INCcl a | $0 | – | -30,000 | -100.0% | -0.06% | – |
| Exit | NEVRO CORPnote 2.750% 4/0 | $0 | – | -2,000,000 | -100.0% | -0.11% | – | |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -67,250 | -100.0% | -0.12% | – |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -268,600 | -100.0% | -0.17% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -171,689 | -100.0% | -0.18% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -678,247 | -100.0% | -0.22% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -429,699 | -100.0% | -0.29% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -326,813 | -100.0% | -0.30% | – |
| Exit | GALAPAGOS NVspon adr | $0 | – | -177,934 | -100.0% | -0.33% | – | |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -708,927 | -100.0% | -0.35% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCcall | $0 | – | -85,000 | -100.0% | -0.43% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -602,100 | -100.0% | -0.46% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -469,664 | -100.0% | -0.50% | – |
| CNC | Exit | CENTENE CORP DELcall | $0 | – | -225,000 | -100.0% | -0.51% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -63,640 | -100.0% | -0.55% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -345,523 | -100.0% | -0.74% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -141,000 | -100.0% | -1.04% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -458,667 | -100.0% | -1.16% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -1,912,188 | -100.0% | -1.36% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -2,807,310 | -100.0% | -2.15% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -901,441 | -100.0% | -5.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.